|
K+8Drug - K+8 The trade name of the product as shown on the labeling.
Dosage -
TABLET, EXTENDED RELEASE; ORAL
Active Ingredient(s) -
Potassium Chloride
Strength -
8MEQ
Applicant -
ALRA
New Drug Application (NDA) Number -
070998
Product Number -
001
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Jan 25, 1993
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Alra Laboratories Inc
K+8
Potassium Chloride 40meq In Plastic Container 2.98gm/100ml Injectable; Injection
Potassium Chloride In Plastic Container 2meq/ml Injectable; Injection Potassium Chloride In Plastic Container 2meq/ml Injectable; Injection K+10 10meq Tablet, Extended Release; Oral K+8 8meq Tablet, Extended Release; Oral Potassium Chloride 20meq In Plastic Container 1.49gm/100ml Injectable; Injection Potassium Chloride 20meq In Plastic Container 29.8mg/ml Injectable; Injection Potassium Chloride 30meq In Plastic Container 2.24gm/100ml Injectable; Injection Potassium Chloride 30meq In Plastic Container 2.24gm/100ml Injectable; Injection Potassium Chloride 40meq In Plastic Container 2.98gm/100ml Injectable; Injection NewDrugInformation |